| 0 (0%) | 11-11 15:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 7.87 | 1-year : | 8.81 |
| Resists | First : | 6.74 | Second : | 7.55 |
| Pivot price | 6.42  |
|||
| Supports | First : | 5.44 | Second : | 4.52 |
| MAs | MA(5) : | 5.88 |
MA(20) : | 6.61 |
| MA(100) : | 4.9  |
MA(250) : | 3.88 |
|
| MACD | MACD : | -0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 11.7 |
D(3) : | 12.6 |
| RSI | RSI(14): 40.5 |
|||
| 52-week | High : | 7.55 | Low : | 2.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AQST ] has closed above bottom band by 9.5%. Bollinger Bands are 54.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.18 - 6.22 | 6.22 - 6.26 |
| Low: | 5.35 - 5.39 | 5.39 - 5.42 |
| Close: | 5.51 - 5.57 | 5.57 - 5.64 |
Tue, 11 Nov 2025
Can AQST stock double in next 5 years - July 2025 Action & Risk Controlled Stock Alerts - newser.com
Mon, 10 Nov 2025
Technical signs of recovery in AQST - Recession Risk & Trade Opportunity Analysis - newser.com
Mon, 10 Nov 2025
Can AQST stock double in next 5 years - Profit Target & AI Forecasted Stock Moves - newser.com
Sat, 08 Nov 2025
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 - Yahoo Finance
Fri, 07 Nov 2025
Piper Sandler Maintains Aquestive Therapeutics (AQST) Overweight Recommendation - Nasdaq
Wed, 05 Nov 2025
Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 121 (M) |
| Shares Float | 96 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 42.8 (%) |
| Shares Short | 12,250 (K) |
| Shares Short P.Month | 8,880 (K) |
| EPS | -0.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.74 |
| Profit Margin | -147.4 % |
| Operating Margin | -113.7 % |
| Return on Assets (ttm) | -31.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -50.3 % |
| Gross Profit (p.s.) | 0.22 |
| Sales Per Share | 0.36 |
| EBITDA (p.s.) | -0.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -50 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -8.24 |
| PEG Ratio | 0 |
| Price to Book value | -7.79 |
| Price to Sales | 15.58 |
| Price to Cash Flow | -13.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|